The role of antimicrobial polypeptides in predicting urinary tract infection: UTILISE study


Yildirim Z. N. Y., Afonso A. C., Akil I., Aksu B., Alpay H., Atmis B., ...Daha Fazla

Pediatric Nephrology, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1007/s00467-026-07578-y
  • Dergi Adı: Pediatric Nephrology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
  • Anahtar Kelimeler: Antimicrobial peptides, Cathelicidin, Children, Urinary tract infection, β-defensin-2
  • Manisa Celal Bayar Üniversitesi Adresli: Evet

Özet

Backgound: Urinary tract infection (UTI) is among the most common serious bacterial infections in childhood. Antimicrobial polypeptides (AMPs) are key effector molecules of the innate immune system and play a crucial role in protecting against infections. The aim of the study was to assess serum and urinary levels of AMPs to determine their ability to distinguish UTI from non-UTI infection, contamination, asymptomatic bacteriuria and healthy control groups. Methods: A total of 520 children between ages 0 and 18 years old with UTI, asymptomatic bacteriuria, contamination, non-UTI infections and healthy controls were participated from 37 pediatric nephrology centers. In all groups, pre-treatment blood and urine samples were obtained before the initiation of antibiotics at the admission. In the UTI group, post-treatment samples were also collected after treatment. Serum and urine levels of cathelicidin, defensin-α, defensin-β, hepcidin, lactoferrin, ribonuclease 7 (RNase7), and secretory leukocyte protease inhibitor were measured by enzyme-linked immunosorbent assay (ELISA) technique. Results: Urinary cathelicidin and β-defensin-2 levels were significantly higher in children with UTI than in all comparator groups (all adjusted p < 0.001). Urinary cathelicidin and β-defensin-2 levels decreased significantly after treatment. Other AMPs did not reliably distinguish UTI from contamination, asymptomatic bacteriuria, or non-UTI infections. ROC analysis showed moderate diagnostic performance for urinary cathelicidin (AUC 0.714) and β-defensin-2 (AUC 0.766). Combining both biomarkers increased specificity (85.4%) but reduced sensitivity (67.5%). Conclusion: Urinary cathelicidin and β-defensin-2 were the most promising biomarkers for pediatric UTI, demonstrating moderate discriminatory ability. Although insufficient as standalone diagnostic tests, they may serve as useful adjunctive tools to improve diagnostic confidence in children with suspected UTI.